This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) project, which was launched in 2015 to overcome barriers to seasonal malaria chemoprevention (SMC) scale-up. By supporting national malaria control/elimination programmes in Burkina Faso, Chad, Guinea, Mali, Niger, Nigeria and The Gambia, the project aimed to provide up to 30 million SMC treatments to 7.5 million under-fives annually. This required a rapid expansion of the global supply of quality-assured and child-friendly SMC treatments by significantly increasing predictable demand through feasible, acceptable and affordable implementation of SMC by national governments.
Country: Burkina Faso | Chad | Guinea | Mali | Niger | Nigeria | The GambiaKeywords: Research | Child and maternal health | Malaria | Preventive treatments | Seasonal malaria chemoprevention | SDG3
« Back to Publications